Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention - grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.
The objective of this study is to conduct the RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) for 12 weeks among Black women who are obese and hypertensive living Chicago. We propose to 1) Pilot the RN-CHEFRx intervention and measures that will be used to assess blood pressure, BMI status, and sodium intake with 20 Black women diagnosed with hypertension and BMI ≥ 30. We will assess the efficacy of the evaluation tools to be used in a future clinical trial at three-time points (baseline, 12 weeks, and 6 months); and 2) Assess the feasibility and acceptability of the RN-CHeFRx intervention using interviews, surveys, and documentary analysis. Findings from this study will inform a larger efficacy trial of RN-CHeFRx to improve dietary behaviors and blood pressure control among Black women with hypertension and obesity.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
18
The RN-CHeFRx trial to enhance dietary intake and blood pressure control in Black women with hypertension and obesity compared to usual care.
University of Illinois Chicago
Chicago, Illinois, United States
Number of participants who complete the 12 week intervention
Completion will be measured by class attendance
Time frame: Up to 12 weeks
Number of participants recruited
Patients recruited, screened, eligible and consented to participate in the study
Time frame: Up to 12 weeks
Number of participants who complete data collection visits
Completion measured by participants completing surveys, blood pressure measurements, and those who provide blood biospecimens
Time frame: Baseline to 4 months
Acceptability of the intervention
Assessed via participant feedback
Time frame: Up to 12 weeks
Change in mean blood pressures (mmHg) during intervention
Change will be measured by comparing blood pressures from baseline to 12 weeks
Time frame: Baseline to 12 weeks
dietary intake during intervention
Dietary intake at baseline and 12 weeks
Time frame: Baseline to 12 weeks
Change in body weight during intervention
Change will be measured by comparing body weight obtained at baseline and 12 weeks
Time frame: Up to 12 weeks
Change in body weight at 6 months
Change will be measured by comparing body weight (kg) obtained at 12 weeks and at 24 weeks.
Time frame: 12 weeks to 24 weeks
Change in blood pressure at 6 months
Change will be measured by comparing systolic and diastolic blood pressure at 12 weeks to 24 weeks
Time frame: 12 weeks to 24 weeks
Dietary intake during post-intervention
Dietary intake from 12 weeks to 24 weeks
Time frame: 12 weeks to 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.